Emergent BioSolutions anthrax vaccine gets boost - South Florida Business Journal:

ibitasony.wordpress.com
The Rockville-based company’s BioThrax has been granted a shelfv life extension from the from its current three years to Under its contract with the Department of Health andHumabn Services, the extension triggers a milestone payment of $30 millionh for doses of the vaccine alreadyh delivered to the Strategic National Stockpile. Emergent expects to recor d that payment as revenuethis quarter.
The shelc life extension also allows Emergen to charge more for future doses of the vaccinr delivered tothe government’s That could raise the value of the contract to as much as $405 million over the next several Last year, the FDA approved a reducec vaccination schedule to five Emergent continues research that could lead to a furthet reduction in the number of doses required, as well as the vaccine’w use to treat patients after being exposed to not just as a pre-exposure vaccine. Emergenr has supplied the government’w stockpile with 33 million doses of BioThraxso far. It is contractedc to continue adding to stockpile throughlate 2011.
BioThrax has been used to vaccinates more than 2 million military personnelk since the government first started buyin the vaccinein 1998. Emergent stock (NYSE: EBS) was up 90 centas to $14.63 per share in afternoon